Ginkgo Bioworks Holdings, Inc. (NYSE: DNA)
$11.1000
-0.0100 ( +2.68% ) 1.4M
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering and BiosecurityThe majority of revenue in the company comes from the Biosecurity segment, which charges fees for data analytics and services.
Market Data
Open
$11.1000
Previous close
$11.1100
Volume
1.4M
Market cap
$638.59M
Day range
$10.5860 - $11.5050
52 week range
$5.2600 - $64.4000
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Aug 06, 2024 |
def | Proxies and info statements | 10 | Jul 05, 2024 |
4 | Insider transactions | 1 | Jul 05, 2024 |
4 | Insider transactions | 1 | Jul 05, 2024 |
pre | Proxies and info statements | 10 | Jun 25, 2024 |
8-k/a | 8K-related | 14 | Jun 24, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |